Introduction
Accurately diagnosing hypertension (HTN) in children and adolescents presents a challenge for medical practitioners. Ambulatory blood pressure monitoring (ABPM) techniques, which capture multiple blood pressure (BP) measurements in a patient's natural environment, provide multiple advantages over standard office-based measurements [1] . Most notably, they capture the natural variability in BP that occurs over an extended time period. ABPM is also correlated closely to morbidity and mortality associated with HTN and to secondary target organ damage in children.
Despite the large variety of ambulatory monitors that are commercially available and their widespread use among pediatric specialists, very few have been independently validated in children [2] [3] [4] . The Spacelabs 90217 ABPM monitor is a light-weight oscillometric monitor with a wide range of BP cuff sizes, making it an ideal monitor for use in a diverse pediatric population. The current study aimed to independently validate the accuracy of this monitor for use in pediatric patients using a modified British Hypertension Society (BHS) protocol [5] .
Methods

Study population and enrollment
Children aged between 6 and less than 18 years were enrolled from three participating sites within the Network of Pediatric Pharmacology Research Units. Eligible participants were required to be free from previously diagnosed cardiac arrhythmias, conditions that might alter normal circulation (i.e. arteriovenous fistula or unrepaired congenital heart disease), and anatomic anomalies preventing BP measurement in the nondominant arm. Participants were also asked to refrain from ingesting caffeine, being exposed (actively or passively) to tobacco, and strenuous exercise for 30 min before BP measurements. Informed parental consent was obtained from all participants, and participant assent was obtained from all children who were 7 years or older. All protocols and procedures were approved by the committee for the protection of human participants at each of the participating institutions.
Enrollment was aimed at generating a cohort of participants with a wide range of ages, BPs, and arm circumferences. Thus, participants were recruited with the goal of having equal enrollment within each of two age groups (6-12 years and 13 to < 18 years). In addition, a minimum of 16.7% of participants within each age group were expected to have a qualifying systolic BP (SBP) less than 1 SD below the participant's mean BP for age, height, and sex [6] ; a qualifying SBP greater than 1 SD above this mean; a qualifying diastolic BP (DBP) less than 1 SD below this mean; and a qualifying DBP greater than 1 SD above this mean. Finally, a minimum of 16.7% of participants within each age group were also required to fit into one of three cuff sizes (child, small adult, and adult for the younger cohort; small adult, adult, and large adult for the older cohort).
Study procedures
Height, weight, mid-arm circumference, and a brief medical history were obtained from all participants. BP was measured while in a seated position using an appropriately sized cuff in the nondominant arm of each participant, alternating between standard auscultatory measures and the Spacelabs 90217 device (King County, Snoqualmie, Washington, USA) as per BHS protocol. Cuff selection was based on the mean of three mid-arm circumference measurements, and the larger cuff was used when the mid-arm circumference fell within the suggested range for two separate cuffs. All auscultatory measurements were obtained simultaneously by two blinded observers using calibrated aneroid devices. The first and fifth Korotkoff sounds were used to define SBP and DBP, respectively. American Heart Association recommendations for measurement of BP [7] were followed throughout the study. Observers responsible for obtaining auscultatory measurements completed centralized training as per American Heart Association recommendations, and serial measurements were validated against those obtained by a single investigator before initiating the study.
Statistical analysis
Nominal demographic characteristics are described as frequencies and percentages. Continuous variables (age) are described as medians and ranges.
Differences in readings between the two devices were calculated for all measurements and all patients. These were used to assess the validation criteria in three ways. First, the mean and SD values of the differences in SBP and DBP were calculated and compared with the validation criterion based on a continuous measure. Second, each difference was classified as up to 5 mmHg, up to 10 mmHg, or up to 15 mmHg, and tabulated to assess the validation based on nominal measures. Finally, the interobserver variability was assessed by comparing the differences between the two raters and classifying them as up to 5 mmHg or up to 10 mmHg.
All analyses were carried out using SAS, v 9.3 (The SAS Institute, Cary, North Carolina, USA).
Results
A total of 157 participants were recruited. Of these, 43 did not complete the study as their qualifying BP readings were outside the range needed for inclusion in the desired cohorts. In addition, the ABPM device failed to read BP in one participant due to persistent movement. One participant was excluded because of the inability of the observers to consistently hear Korotkoff sounds. Demographic data for the remaining 112 children who successfully completed the protocol are shown in Table 1 . Recruitment goals for varying ages, cuff sizes, and BP ranges were met for all cohorts except for the low DBP group, in which only 10.7% of participants were classified (goal 16.7%). Interobserver variability differed by up to 5 mmHg in 82.7% of readings and by up to Based on the mean of two observers' auscultatory values: low, < 1 SD below the mean; normal, > 1 SD below the mean but < 1 SD above the mean; high, > 1 SD above the mean. 10 mmHg in 97.2% of readings, satisfying the requirements of the BHS for a valid study (>80% and > 95% required, respectively).
The cumulative percentage of readings between the two devices, which differed by less than or equal to 5, 10, and 15 mmHg for the overall cohort and by age group, is shown in 
Discussion
We conclude that the Spacelabs 90217 ABPM accurately measures BP across a diverse pediatric population. The previous Spacelabs model 90207 received a grade of 'C' for SBP and 'D' for DBP in an independent validation study [2] . This is considerably worse than the results of our study, suggesting that the 90217 model is a better choice for pediatricians performing ABPM. However, there is still some concern with regard to DBP measurement in children, as the monitor did not completely fulfill Association for the Advancement of Medical Instrumentation criteria for diastolic variability. In an effort to standardize the criteria for DBP, the fifth Korotkoff sound was used to determine DBP for all participants. Consequently, a small number of participants for whom the fourth Korotkoff sound may have been more clinically appropriate had an auscultatory DBP < 10 mmHg. The authors speculate that this is the reason for the larger than acceptable difference in SD between the measures.
Although multiple ambulatory monitors are commercially available, few have been independently validated in children. Jones et al. [3] validated the AM5600 (Advanced Biosensor, Inc., Columbia, South Carolina, USA) in 7-18 year olds with a history of elevated BP or with a first-degree relative with HTN. The Tiba Medical Ambulo 2400 ABPM device (Tiba Medical, Inc., Portland, Oregon, USA) has also been validated using International Standards Organization guidelines, which are used to validate monitors in populations that include both children and adults [4] . Unfortunately, other devices that have been validated in children are no longer commercially available.
The most comprehensive recommendations for validating BP measuring devices, specifically in children, are provided by the revised BHS protocol published in 1992. These guidelines call for the inclusion of 30 participants of either sex, aged between 5 and 15 years, with a specified range for baseline SBP, DBP, and arm circumference. Given the heterogeneity of BP in children and the vascular changes that occur during puberty, the authors believe that these recommendations limit the ability to effectively validate a BP device across this age span. Thus, we increased our enrollment size, with a goal of being able to evaluate the monitor independently in two different age groups.
In addition, entry criteria for this study were aimed at recruiting a range of cuff sizes rather than the populationbased range of mid-arm circumferences suggested by the BHS. Normal values for mid-arm circumference are dated, and with the recent obesity epidemic, they are unlikely to represent the intent of the validation protocol, which is to measure BP across a wide range of expected arm sizes. Only one participant in our study required the 'extra-large' cuff; thus, the validity of the monitor for extremely obese individuals remains unknown.
Recommendations also call for validation of new devices against a mercury manometer. Environmental concerns and subsequent governmental regulations have decreased the availability of mercury manometers; hence, aneroid devices were utilized in this study. To minimize the potential variability associated with aneroid devices, new devices dedicated solely to this project were purchased and were centrally calibrated before starting the protocol. Enrollment was completed in less than 6 months; hence, the monitors were not recalibrated. Interobserver variability did not change throughout the study, suggesting that no significant drift occurred with the aneroid devices.
Finally, recruitment into the 'DBP less than 1 SD below the mean' cohort was challenging. It is suspected that a drift in the mean BP has occurred over time with the rising rate of obesity in our country [8] , making this already small group even harder to identify. Overall, 12 participants fell into this low DBP group (five and seven participants in the younger and older age cohorts, respectively). An additional 43 participants were screened in an effort to complete this cohort. Original BHS criteria require five participants of 30 to fall into this range. Thus, although the study failed to recruit the required percentage of children with a low DBP, it did identify over twice as many children as the original protocol dictates.
Despite these limitations, the study population represents children with a wide range of ages, baseline BPs, and arm sizes. In addition, the study was successfully performed at multiple sites, demonstrating the monitor's ease of use in multiple settings by multiple personnel. As a successor to the ambulatory monitor from which the most widely used pediatric normal values were generated [9] , the Spacelabs 90217 has been used frequently for both clinical and research applications despite having never undergone rigorous, independent validation. This study supports the continued use of this monitor in the pediatric population and endorses a wealth of published data demonstrating the superiority of ABPM over casual BP measurements in evaluating children with elevated BP.
